Page last updated: 2024-09-03

5-(tetradecyloxy)-2-furancarboxylic acid and Carcinoma

5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, MB; Glover, RA; Guseva, NV; Rokhlin, OW1

Other Studies

1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and Carcinoma

ArticleYear
TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status.
    Cancer biology & therapy, 2011, Jul-01, Volume: 12, Issue:1

    Topics: Acetyl-CoA Carboxylase; Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Death; Cell Line, Tumor; Cytochromes c; Dihydrotestosterone; Fatty Acids; Furans; Genes, p53; Humans; Introns; Lipids; Male; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neuropilin-1; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen

2011